Blood test may predict who needs early treatment for lung failure
NCT ID NCT07334379
First seen Jan 12, 2026 · Last updated May 15, 2026 · Updated 15 times
Summary
This study looks at whether measuring a blood marker called IL-6 can help doctors decide when to give extra treatment to patients hospitalized with severe breathing problems. About 60 adults will have their IL-6 levels checked over two days. Those with high levels will receive either standard care alone, standard care plus tocilizumab, or standard care plus dexamethasone. The goal is to see if this approach is practical and can prevent the condition from getting worse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE HYPOXEMIC RESPIRATORY FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Toronto General Hospital
RECRUITINGToronto, Ontario, M5G 2N2, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.